Global Neurorehabilitation Devices Market Analysis and Forecast 2024-2030

Global Neurorehabilitation Devices Market Analysis and Forecast 2024-2030


Summary

According to APO Research, The global Neurorehabilitation Devices market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Neurorehabilitation Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Neurorehabilitation Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Neurorehabilitation Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Neurorehabilitation Devices is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Neurorehabilitation Devices include Medtronic, Abbott Laboratories, Boston Scientific, Bioness, Hocoma AG, Neuronetics, Yiruide, Magstim and VISHEE, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Neurorehabilitation Devices, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Neurorehabilitation Devices, also provides the revenue of main regions and countries. Of the upcoming market potential for Neurorehabilitation Devices, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Neurorehabilitation Devices revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Neurorehabilitation Devices market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Neurorehabilitation Devices revenue, projected growth trends, production technology, application and end-user industry.

Neurorehabilitation Devices segment by Company

Medtronic
Abbott Laboratories
Boston Scientific
Bioness
Hocoma AG
Neuronetics
Yiruide
Magstim
VISHEE
Ekso Bionics
Alter G
MagVenture
Tyromotion
Soterix Medical
Neuroelectrics
Bionik Laboratories
Helius Medical
Neurorehabilitation Devices segment by Type

Implantable Neurorehabilitation System
Neurorobotic System
Brain Computer Interface
Non-invasive Stimulators
Other
Neurorehabilitation Devices segment by Application

Hospitals
Clinics
Other
Neurorehabilitation Devices segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurorehabilitation Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neurorehabilitation Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurorehabilitation Devices.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Neurorehabilitation Devices in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Neurorehabilitation Devices company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neurorehabilitation Devices revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Neurorehabilitation Devices Market by Type
1.2.1 Global Neurorehabilitation Devices Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Implantable Neurorehabilitation System
1.2.3 Neurorobotic System
1.2.4 Brain Computer Interface
1.2.5 Non-invasive Stimulators
1.2.6 Other
1.3 Neurorehabilitation Devices Market by Application
1.3.1 Global Neurorehabilitation Devices Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Neurorehabilitation Devices Market Dynamics
2.1 Neurorehabilitation Devices Industry Trends
2.2 Neurorehabilitation Devices Industry Drivers
2.3 Neurorehabilitation Devices Industry Opportunities and Challenges
2.4 Neurorehabilitation Devices Industry Restraints
3 Global Growth Perspective
3.1 Global Neurorehabilitation Devices Market Perspective (2019-2030)
3.2 Global Neurorehabilitation Devices Growth Trends by Region
3.2.1 Global Neurorehabilitation Devices Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Neurorehabilitation Devices Market Size by Region (2019-2024)
3.2.3 Global Neurorehabilitation Devices Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Neurorehabilitation Devices Revenue by Players
4.1.1 Global Neurorehabilitation Devices Revenue by Players (2019-2024)
4.1.2 Global Neurorehabilitation Devices Revenue Market Share by Players (2019-2024)
4.1.3 Global Neurorehabilitation Devices Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Neurorehabilitation Devices Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Neurorehabilitation Devices Key Players Headquarters & Area Served
4.4 Global Neurorehabilitation Devices Players, Product Type & Application
4.5 Global Neurorehabilitation Devices Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Neurorehabilitation Devices Market CR5 and HHI
4.6.2 Global Top 5 and 10 Neurorehabilitation Devices Players Market Share by Revenue in 2023
4.6.3 2023 Neurorehabilitation Devices Tier 1, Tier 2, and Tier 3
5 Neurorehabilitation Devices Market Size by Type
5.1 Global Neurorehabilitation Devices Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Neurorehabilitation Devices Revenue by Type (2019-2030)
5.3 Global Neurorehabilitation Devices Revenue Market Share by Type (2019-2030)
6 Neurorehabilitation Devices Market Size by Application
6.1 Global Neurorehabilitation Devices Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Neurorehabilitation Devices Revenue by Application (2019-2030)
6.3 Global Neurorehabilitation Devices Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Medtronic
7.1.1 Medtronic Comapny Information
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
7.1.4 Medtronic Neurorehabilitation Devices Product Portfolio
7.1.5 Medtronic Recent Developments
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Comapny Information
7.2.2 Abbott Laboratories Business Overview
7.2.3 Abbott Laboratories Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
7.2.4 Abbott Laboratories Neurorehabilitation Devices Product Portfolio
7.2.5 Abbott Laboratories Recent Developments
7.3 Boston Scientific
7.3.1 Boston Scientific Comapny Information
7.3.2 Boston Scientific Business Overview
7.3.3 Boston Scientific Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
7.3.4 Boston Scientific Neurorehabilitation Devices Product Portfolio
7.3.5 Boston Scientific Recent Developments
7.4 Bioness
7.4.1 Bioness Comapny Information
7.4.2 Bioness Business Overview
7.4.3 Bioness Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
7.4.4 Bioness Neurorehabilitation Devices Product Portfolio
7.4.5 Bioness Recent Developments
7.5 Hocoma AG
7.5.1 Hocoma AG Comapny Information
7.5.2 Hocoma AG Business Overview
7.5.3 Hocoma AG Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
7.5.4 Hocoma AG Neurorehabilitation Devices Product Portfolio
7.5.5 Hocoma AG Recent Developments
7.6 Neuronetics
7.6.1 Neuronetics Comapny Information
7.6.2 Neuronetics Business Overview
7.6.3 Neuronetics Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
7.6.4 Neuronetics Neurorehabilitation Devices Product Portfolio
7.6.5 Neuronetics Recent Developments
7.7 Yiruide
7.7.1 Yiruide Comapny Information
7.7.2 Yiruide Business Overview
7.7.3 Yiruide Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
7.7.4 Yiruide Neurorehabilitation Devices Product Portfolio
7.7.5 Yiruide Recent Developments
7.8 Magstim
7.8.1 Magstim Comapny Information
7.8.2 Magstim Business Overview
7.8.3 Magstim Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
7.8.4 Magstim Neurorehabilitation Devices Product Portfolio
7.8.5 Magstim Recent Developments
7.9 VISHEE
7.9.1 VISHEE Comapny Information
7.9.2 VISHEE Business Overview
7.9.3 VISHEE Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
7.9.4 VISHEE Neurorehabilitation Devices Product Portfolio
7.9.5 VISHEE Recent Developments
7.10 Ekso Bionics
7.10.1 Ekso Bionics Comapny Information
7.10.2 Ekso Bionics Business Overview
7.10.3 Ekso Bionics Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
7.10.4 Ekso Bionics Neurorehabilitation Devices Product Portfolio
7.10.5 Ekso Bionics Recent Developments
7.11 Alter G
7.11.1 Alter G Comapny Information
7.11.2 Alter G Business Overview
7.11.3 Alter G Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
7.11.4 Alter G Neurorehabilitation Devices Product Portfolio
7.11.5 Alter G Recent Developments
7.12 MagVenture
7.12.1 MagVenture Comapny Information
7.12.2 MagVenture Business Overview
7.12.3 MagVenture Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
7.12.4 MagVenture Neurorehabilitation Devices Product Portfolio
7.12.5 MagVenture Recent Developments
7.13 Tyromotion
7.13.1 Tyromotion Comapny Information
7.13.2 Tyromotion Business Overview
7.13.3 Tyromotion Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
7.13.4 Tyromotion Neurorehabilitation Devices Product Portfolio
7.13.5 Tyromotion Recent Developments
7.14 Soterix Medical
7.14.1 Soterix Medical Comapny Information
7.14.2 Soterix Medical Business Overview
7.14.3 Soterix Medical Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
7.14.4 Soterix Medical Neurorehabilitation Devices Product Portfolio
7.14.5 Soterix Medical Recent Developments
7.15 Neuroelectrics
7.15.1 Neuroelectrics Comapny Information
7.15.2 Neuroelectrics Business Overview
7.15.3 Neuroelectrics Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
7.15.4 Neuroelectrics Neurorehabilitation Devices Product Portfolio
7.15.5 Neuroelectrics Recent Developments
7.16 Bionik Laboratories
7.16.1 Bionik Laboratories Comapny Information
7.16.2 Bionik Laboratories Business Overview
7.16.3 Bionik Laboratories Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
7.16.4 Bionik Laboratories Neurorehabilitation Devices Product Portfolio
7.16.5 Bionik Laboratories Recent Developments
7.17 Helius Medical
7.17.1 Helius Medical Comapny Information
7.17.2 Helius Medical Business Overview
7.17.3 Helius Medical Neurorehabilitation Devices Revenue and Gross Margin (2019-2024)
7.17.4 Helius Medical Neurorehabilitation Devices Product Portfolio
7.17.5 Helius Medical Recent Developments
8 North America
8.1 North America Neurorehabilitation Devices Revenue (2019-2030)
8.2 North America Neurorehabilitation Devices Revenue by Type (2019-2030)
8.2.1 North America Neurorehabilitation Devices Revenue by Type (2019-2024)
8.2.2 North America Neurorehabilitation Devices Revenue by Type (2025-2030)
8.3 North America Neurorehabilitation Devices Revenue Share by Type (2019-2030)
8.4 North America Neurorehabilitation Devices Revenue by Application (2019-2030)
8.4.1 North America Neurorehabilitation Devices Revenue by Application (2019-2024)
8.4.2 North America Neurorehabilitation Devices Revenue by Application (2025-2030)
8.5 North America Neurorehabilitation Devices Revenue Share by Application (2019-2030)
8.6 North America Neurorehabilitation Devices Revenue by Country
8.6.1 North America Neurorehabilitation Devices Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Neurorehabilitation Devices Revenue by Country (2019-2024)
8.6.3 North America Neurorehabilitation Devices Revenue by Country (2025-2030)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Neurorehabilitation Devices Revenue (2019-2030)
9.2 Europe Neurorehabilitation Devices Revenue by Type (2019-2030)
9.2.1 Europe Neurorehabilitation Devices Revenue by Type (2019-2024)
9.2.2 Europe Neurorehabilitation Devices Revenue by Type (2025-2030)
9.3 Europe Neurorehabilitation Devices Revenue Share by Type (2019-2030)
9.4 Europe Neurorehabilitation Devices Revenue by Application (2019-2030)
9.4.1 Europe Neurorehabilitation Devices Revenue by Application (2019-2024)
9.4.2 Europe Neurorehabilitation Devices Revenue by Application (2025-2030)
9.5 Europe Neurorehabilitation Devices Revenue Share by Application (2019-2030)
9.6 Europe Neurorehabilitation Devices Revenue by Country
9.6.1 Europe Neurorehabilitation Devices Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Neurorehabilitation Devices Revenue by Country (2019-2024)
9.6.3 Europe Neurorehabilitation Devices Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Netherlands
9.6.9 Nordic Countries
10 China
10.1 China Neurorehabilitation Devices Revenue (2019-2030)
10.2 China Neurorehabilitation Devices Revenue by Type (2019-2030)
10.2.1 China Neurorehabilitation Devices Revenue by Type (2019-2024)
10.2.2 China Neurorehabilitation Devices Revenue by Type (2025-2030)
10.3 China Neurorehabilitation Devices Revenue Share by Type (2019-2030)
10.4 China Neurorehabilitation Devices Revenue by Application (2019-2030)
10.4.1 China Neurorehabilitation Devices Revenue by Application (2019-2024)
10.4.2 China Neurorehabilitation Devices Revenue by Application (2025-2030)
10.5 China Neurorehabilitation Devices Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Neurorehabilitation Devices Revenue (2019-2030)
11.2 Asia Neurorehabilitation Devices Revenue by Type (2019-2030)
11.2.1 Asia Neurorehabilitation Devices Revenue by Type (2019-2024)
11.2.2 Asia Neurorehabilitation Devices Revenue by Type (2025-2030)
11.3 Asia Neurorehabilitation Devices Revenue Share by Type (2019-2030)
11.4 Asia Neurorehabilitation Devices Revenue by Application (2019-2030)
11.4.1 Asia Neurorehabilitation Devices Revenue by Application (2019-2024)
11.4.2 Asia Neurorehabilitation Devices Revenue by Application (2025-2030)
11.5 Asia Neurorehabilitation Devices Revenue Share by Application (2019-2030)
11.6 Asia Neurorehabilitation Devices Revenue by Country
11.6.1 Asia Neurorehabilitation Devices Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Neurorehabilitation Devices Revenue by Country (2019-2024)
11.6.3 Asia Neurorehabilitation Devices Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Neurorehabilitation Devices Revenue (2019-2030)
12.2 MEALA Neurorehabilitation Devices Revenue by Type (2019-2030)
12.2.1 MEALA Neurorehabilitation Devices Revenue by Type (2019-2024)
12.2.2 MEALA Neurorehabilitation Devices Revenue by Type (2025-2030)
12.3 MEALA Neurorehabilitation Devices Revenue Share by Type (2019-2030)
12.4 MEALA Neurorehabilitation Devices Revenue by Application (2019-2030)
12.4.1 MEALA Neurorehabilitation Devices Revenue by Application (2019-2024)
12.4.2 MEALA Neurorehabilitation Devices Revenue by Application (2025-2030)
12.5 MEALA Neurorehabilitation Devices Revenue Share by Application (2019-2030)
12.6 MEALA Neurorehabilitation Devices Revenue by Country
12.6.1 MEALA Neurorehabilitation Devices Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Neurorehabilitation Devices Revenue by Country (2019-2024)
12.6.3 MEALA Neurorehabilitation Devices Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings